Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?

The concept of induction treatment followed by long-term maintenance treatment in multiple sclerosis (MS) has attracted considerable attention. The combination of mitoxantrone as the induction therapy followed by an immunomodulatory drug (e.g., interferon beta or glatiramer acetate) as the maintenan...

Descripción completa

Detalles Bibliográficos
Autores principales: Edan, Gilles, Le Page, Emmanuelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680663/
https://www.ncbi.nlm.nih.gov/pubmed/23657788
http://dx.doi.org/10.1007/s40263-013-0065-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680663/
https://www.ncbi.nlm.nih.gov/pubmed/23657788
http://dx.doi.org/10.1007/s40263-013-0065-y

Ejemplares similares